Comprehensive genome sequencing of the liver cancer genome.
暂无分享,去创建一个
[1] Boping Zhou,et al. Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.
[2] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[3] Robert M Hoffman,et al. The challenges posed by cancer heterogeneity , 2012, Nature Biotechnology.
[4] Keith A. Boroevich,et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.
[5] Angela M. Liu,et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma , 2012, Nature Genetics.
[6] S. Imbeaud,et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma , 2012, Nature Genetics.
[7] H. El‐Serag,et al. Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.
[8] K. Polyak,et al. Intra-tumour heterogeneity: a looking glass for cancer? , 2012, Nature Reviews Cancer.
[9] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[10] Thomas D. Wu,et al. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. , 2012, Genome research.
[11] Philippe P Roux,et al. Regulation and function of the RSK family of protein kinases. , 2012, The Biochemical journal.
[12] Tian-Li Wang,et al. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.
[13] Michael A Choti,et al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma , 2011, Nature Genetics.
[14] Christopher D. Brown,et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data , 2011, Proceedings of the National Academy of Sciences.
[15] C. Roberts,et al. SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.
[16] Hidenori Ojima,et al. High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.
[17] Jannik N. Andersen,et al. Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.
[18] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[19] E. Wagner,et al. Mitogen‐inducible gene‐6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma , 2010, Hepatology.
[20] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[21] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[22] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[23] M. Hung,et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. , 2009, Molecular cell.
[24] Derek Y. Chiang,et al. Pathogenesis of hepatocellular carcinoma and molecular therapies , 2009, Current opinion in gastroenterology.
[25] S. Altekruse,et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Maguire,et al. Solution Hybrid Selection with Ultra-long Oligonucleotides for Massively Parallel Targeted Sequencing , 2009, Nature Biotechnology.
[27] S. V. van Heeringen,et al. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response , 2008, Nucleic acids research.
[28] Tsutomu Ohta,et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy , 2008, Proceedings of the National Academy of Sciences.
[29] R. Reddel,et al. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells , 2008, Cancer science.
[30] Takehide Asano,et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed‐lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma , 2008, Human mutation.
[31] Ron Bose,et al. Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface , 2007, Nature.
[32] S. Hirohashi,et al. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. , 2007, Gastroenterology.
[33] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[34] C. Bradbury,et al. Cross-talk between Histone Modifications in Response to Histone Deacetylase Inhibitors , 2007, Journal of Biological Chemistry.
[35] S. Boyault,et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.
[36] H. Eguchi,et al. Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma , 2006, Annals of surgery.
[37] Kairong Cui,et al. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. , 2005, Genes & development.
[38] P. Dallas,et al. Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. , 2004, The Biochemical journal.
[39] Yoshiki Murakami,et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene , 2003, Oncogene.
[40] S. Thorgeirsson,et al. Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.
[41] G. Blanck,et al. Interferon regulatory factor‐2 point mutations in human pancreatic tumors , 2000, International journal of cancer.
[42] M. Yaniv,et al. Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex. , 1996, The EMBO journal.
[43] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[44] C. Bréchot,et al. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.
[45] J. Maller,et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.
[46] Christine Pourcel,et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma , 1980, Nature.